Patricia L Allen - Net Worth and Insider Trading
Patricia L Allen Net Worth
The estimated net worth of Patricia L Allen is at least $289,409 dollars as of 2024-11-13. Patricia L Allen is the VP of Finance and Treasurer of Alnylam Pharmaceuticals Inc and owns about 1,070 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $287,777. Patricia L Allen is the CFO of Zafgen Inc and owns about 1,649 shares of Zafgen Inc (ZFGN) stock worth over $1,633. Patricia L Allen is also the Director of Deciphera Pharmaceuticals Inc and owns about 0 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $0. Details can be seen in Patricia L Allen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patricia L Allen has not made any transactions after 2020-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patricia L Allen
Patricia L Allen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patricia L Allen owns 5 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Larimar Therapeutics Inc (LRMR) , and Alnylam Pharmaceuticals Inc (ALNY) among others .
Click here to see the complete history of Patricia L Allen’s form 4 insider trades.
Insider Ownership Summary of Patricia L Allen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DCPH | Deciphera Pharmaceuticals Inc | 2020-06-05 | director |
LRMR | Larimar Therapeutics Inc | 2016-03-31 | Chief Financial Officer |
ALNY | Alnylam Pharmaceuticals Inc | 2006-01-01 | VP of Finance and Treasurer |
2020-12-22 | director | ||
2020-12-22 | director |
Patricia L Allen Latest Holdings Summary
Patricia L Allen currently owns a total of 3 stocks. Among these stocks, Patricia L Allen owns 1,070 shares of Alnylam Pharmaceuticals Inc (ALNY) as of January 1, 2006, with a value of $287,777 and a weighting of 99.44%. Patricia L Allen owns 1,649 shares of Zafgen Inc (ZFGN) as of July 26, 2016, with a value of $1,633 and a weighting of 0.56%. Patricia L Allen also owns 0 shares of Deciphera Pharmaceuticals Inc (DCPH) as of June 5, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Patricia L Allen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2006-01-01 | 1,070 | 268.95 | 287,777 |
ZFGN | Zafgen Inc | 2016-07-26 | 1,649 | 0.99 | 1,633 |
DCPH | Deciphera Pharmaceuticals Inc | 2020-06-05 | 0 | 25.59 | 0 |
Holding Weightings of Patricia L Allen
Patricia L Allen Form 4 Trading Tracker
According to the SEC Form 4 filings, Patricia L Allen has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on January 1, 2006, which brought Patricia L Allen around $0.
According to the SEC Form 4 filings, Patricia L Allen has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the acquisition of 1,333 shares on July 26, 2016, which cost Patricia L Allen around $49,920.
According to the SEC Form 4 filings, Patricia L Allen has made a total of 2 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 12,000 shares on June 5, 2020, which brought Patricia L Allen around $691,440.
Insider Trading History of Patricia L Allen
- 1
Patricia L Allen Trading Performance
GuruFocus tracks the stock performance after each of Patricia L Allen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patricia L Allen is 9.06%. GuruFocus also compares Patricia L Allen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patricia L Allen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patricia L Allen's insider trading performs compared to the benchmark.
Performance of Patricia L Allen
Patricia L Allen Ownership Network
Ownership Network List of Patricia L Allen
Ownership Network Relation of Patricia L Allen
Patricia L Allen Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Patricia L Allen is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Patricia L Allen made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Patricia L Allen Mailing Address
Above is the net worth, insider trading, and ownership report for Patricia L Allen. You might contact Patricia L Allen via mailing address: C/o Deciphera Pharmaceuticals, Inc, 200 Smith Street, Waltham Ma 02451.